Breaking News: APA Updates Guidelines for Borderline Personality Disorder

After a two-decade gap, the American Psychiatric Association (APA) has released updated clinical practice guidelines for borderline personality disorder (BPD), marking a significant milestone in BPD treatment. The new guidelines, published in the esteemed American Journal of Psychiatry, provide clinicians with evidence-based recommendations for improving the diagnosis, assessment, and treatment of BPD.

A Rich Resource for Clinicians

Dr. John Oldham, MS, MD, a member of the guideline writing group and distinguished emeritus professor at Baylor College of Medicine, believes this comprehensive update is a valuable resource for any clinician working with patients with BPD. “The new guideline is quite substantial and really serves as a rich textbook of the literature about borderline personality disorder,” Dr. Oldham told Medscape Medical News.

The primary goal of these updated guidelines is to elevate the quality of care and treatment outcomes for individuals diagnosed with BPD.

Key Recommendations for BPD Treatment

The guidelines encompass eight evidence-based recommendations, covering key aspects of BPD management, including:

• Initial Assessment: The guidelines emphasize a thorough initial assessment that encompasses the patient’s reasons for seeking treatment, their goals, psychiatric symptoms, co-occurring disorders, treatment history, medical status, psychosocial factors, mental status, and risk factors for suicide, self-harm, or aggression.

• Symptom Measurement: The guidelines suggest using quantitative measures to assess symptom severity and functional impairment, selecting from a range of validated tools, such as the Borderline Symptom List, the Borderline Evaluation of Severity Over Time, the 11-item Borderline Personality Features Scale for Children, or the Difficulty in Emotional Regulation Scale.

• Structured Psychotherapy:

These guidelines strongly recommend structured psychotherapy approaches with a proven track record in treating BPD. Dialectical behavior therapy and mentalization-based therapy are highlighted as effective modalities, along with other therapies demonstrating efficacy in recent research.

• Medication Management:

The guidelines recommend a time-limited, symptom-focused approach to medication treatment, emphasizing that medications should complement, not replace, psychotherapy.

“Medication is not a primary treatment but may help diminish symptoms such as affective instability, impulsivity, or psychotic-like symptoms in individual patients, helping them to remain engaged in treatment or reducing short-term risks of self-harm,” explained Dr. Oldham.

• Regular Medication Review: The guidelines stress the importance of periodic medication reviews every 6 months to evaluate effectiveness and identify medications requiring adjustments or discontinuation.

The Alternative Model for Personality Disorders (AMPD)

Dr. Oldham notes that the Alternative DSM-5 Model for Personality Disorders (AMPD) is gaining traction in clinical settings, offering a potential shift from the traditional categorical approach to personality disorder diagnosis. The AMPD views personality disorders along a spectrum of severity and emphasizes individualized treatment plans that acknowledge the variability and overlap of symptoms.

While promising, Dr. Oldham acknowledges that further research using the AMPD in clinical trials is needed before it can be fully integrated into the guidelines.

A Continuing Commitment to BPD Care

These updated guidelines represent a significant step forward in our understanding and treatment of borderline personality disorder. By providing clinicians with evidence-based recommendations and fostering a more nuanced approach to diagnosis and care, the APA is committed to improving the lives of individuals living with BPD.

Are you a mental health professional? Learn more about the updated APA guidelines for BPD treatment and resources available to support your patients.